61-75 of 86
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Akshay S. Desai, MD
John McMurray, MD
John McMurray, MD
Hiddo L. Heerspink, PhD
John McMurray, MD
Pardeep Jhund, MD, PhD
John McMurray, MD
Hiddo L. Heerspink, PhD
Pardeep Jhund, MD, PhD
Hiddo L. Heerspink, PhD
John McMurray, MD
Akshay S. Desai, MD
Csaba P. Kovesdy, MD
Finnian R. McCausland, MD
Orly Vardeny, MD
Muthiah Vaduganathan, MD, MPH
Pardeep Jhund, MD, PhD
John McMurray, MD
- advertisement
Overcoming Clinical Inertia in Hyperkalemia Management
CME/CEOvercoming Clinical Inertia in Hyperkalemia Management
Peter Rossing, MD, DMSc
Michael Böhm, MD
Luca De Nicola, MD, PhD
Emerging Therapeutics in ADH1: Progress in Precision Medicine
MinuteCE®Emerging Therapeutics in ADH1: Progress in Precision Medicine
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®Therapeutic Options for ADH1 and Hypoparathyroidism
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®CASR and ADH1: Integrating Biology and Genetic Screening
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
- advertisement
Revolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
CME/CERevolutionizing Care for Patients With T2D and Obesity: From Pathophysiology to Personalized Treatments
Scott Kahan, MD, MPH
Ken Fujioka, MD
Carol Wysham, MD
Maria Fleseriu, MD, FACE
Richard Auchus, MD
Martin Reincke, MD
Richard Auchus, MD
